Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fusion protein constructs comprising anti-C3d antibody and CR1 polypeptide

Fusion protein constructs comprising anti-C3d antibody and CR1 polypeptide

US Patent 11053305 · Granted Jul 6, 2021

Estimated economic value: $2,960,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

WRN inhibitors2025
WRN inhibitors2025
Modulation of gene transcription using antisense oligonucleotides targeting regu2025
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inh2025
Inhibiting deubiquitinase USP25 and USP282025
Carboxamides as ubiquitin-specific protease inhibitors2024
Purinones as ubiquitin-specific protease 1 inhibitors2024
Anti-VLA-4 antibodies having reduced effector function2024
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors2024
Humanized anti-complement factor Bb antibodies and uses thereof2024
Methods of treating complement mediated diseases with fusion protein constructs 2024
Methods of treating complement mediated diseases with fusion protein constructs 2024